Skip to main content

Table 3 Pearson's correlations between plasma endoglin and basal glycemia, glycated hemoglobin and cardiovascular parameters

From: Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients

 

All DIA R P value

DIA without HYP

R P value

DIA with HYP

R P value

All HYP

R P value

HYP without DIA

R P value

Control

R P value

Basal glycemia

0.221 0.079

-0.230 0.304

0.360 0.019a

0.065 0.388

-0.130 0.128

-0.095 0.451

Glycated hemoglobin

0.257 0.042a

0.347 0.114

0.239 0.132

0.008 0.912

-0.118 0.167

-0.097 0.451

Systolic blood pressure

0.243 0.053

-0.072 0.751

0.381 0.013a

0.183 0.031a

0.009 0.918

-0.076 0.547

Pulse pressure

0.326 0.009a

-0.150 0.506

0.519 0.000a

0.118 0.115

-0.024 0.784

0.064 0.611

Systolic night-day ratio

-0.109 0.391

-0.481 0.019a

0.037 0.817

-0.033 0.665

-0.063 0.468

0.009 0.946

Heart rate

0.053 0.678

0.508 0.016a

-0.141 0.374

-0.054 0.474

-0.023 0.788

-0.232 0.064

Pulse wave velocity

0.194 0.127

-0.131 0.562

0.348 0.026a

0.009 0.905

-0.096 0.262

-0.144 0.251

VDP Cornell

0.382 0.002a

0.273 0.219

0.439 0.004a

0.148 0.047a

0.027 0.752

-0.171 0.174

Sokolow index

0.223 0.076

0.127 0.575

0.294 0.058

0.151 0.043a

0.093 0.281

0.071 0.575

  1. DIA, diabetic patients; HYP, hypertension; R, correlation coefficient; VDP, voltage-duration product. aStatistically significant differences (P < 0.05).